Clot Stiffness Measured By Seer Sonorheometry As a Marker Of Poor Prognosis In Hospitalized COVID-19 Patients
A high risk of thrombotic complications has been observed among severely ill COVID-19 patients. Viscoelastic tests (VET) have shown a hypercoagulable profile in these patients, although so far there is no clear evidence on the use of these tools as predictors of risk in the clinical course of patients. In this study we aimed to evaluate the association between Quantra® sonorheometry VET parameters, standard coagulation tests and inflammatory markers in 69 patients with COVID-19 on hospital admission with disease severity and outcome. Inflammatory markers were elevated in a high percentage of patients, as were coagulation-related parameters such as fibrinogen and D-dimer levels. Quantra® sonorheometry analysis revealed increased clot stiffness (CS), especially due to increased fibrinogen contribution (FCS) in 63.7%. Analysis of clot stability to lysis (CSL) on the Quantra showed a value of 100%, suggesting hypofibrinolysis, in 32.4%. Age > 65 years, elevated values of fibrinogen, D-dimer, LDH, increased CS and CSL were significantly associated with worsening disease. The combination of elevated FCS and D-dimer values showed a particularly high prognostic value in distinguishing patients with severe symptomatology. In conclusion, FCS measured by Quantra® system and its combination with D-dimer could be established as a powerful tool to identify poor prognosis in COVID-19 patients on hospital admission.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
---|---|
Enthalten in: |
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis - 28(2022) vom: 01. Jan., Seite 10760296221112085 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
López-Jaime, Francisco José [VerfasserIn] |
---|
Links: |
---|
Themen: |
9001-32-5 |
---|
Anmerkungen: |
Date Completed 01.08.2022 Date Revised 03.08.2022 published: Print Citation Status MEDLINE |
---|
doi: |
10.1177/10760296221112085 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM344236684 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM344236684 | ||
003 | DE-627 | ||
005 | 20231226022309.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1177/10760296221112085 |2 doi | |
028 | 5 | 2 | |a pubmed24n1147.xml |
035 | |a (DE-627)NLM344236684 | ||
035 | |a (NLM)35903939 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a López-Jaime, Francisco José |e verfasserin |4 aut | |
245 | 1 | 0 | |a Clot Stiffness Measured By Seer Sonorheometry As a Marker Of Poor Prognosis In Hospitalized COVID-19 Patients |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.08.2022 | ||
500 | |a Date Revised 03.08.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a A high risk of thrombotic complications has been observed among severely ill COVID-19 patients. Viscoelastic tests (VET) have shown a hypercoagulable profile in these patients, although so far there is no clear evidence on the use of these tools as predictors of risk in the clinical course of patients. In this study we aimed to evaluate the association between Quantra® sonorheometry VET parameters, standard coagulation tests and inflammatory markers in 69 patients with COVID-19 on hospital admission with disease severity and outcome. Inflammatory markers were elevated in a high percentage of patients, as were coagulation-related parameters such as fibrinogen and D-dimer levels. Quantra® sonorheometry analysis revealed increased clot stiffness (CS), especially due to increased fibrinogen contribution (FCS) in 63.7%. Analysis of clot stability to lysis (CSL) on the Quantra showed a value of 100%, suggesting hypofibrinolysis, in 32.4%. Age > 65 years, elevated values of fibrinogen, D-dimer, LDH, increased CS and CSL were significantly associated with worsening disease. The combination of elevated FCS and D-dimer values showed a particularly high prognostic value in distinguishing patients with severe symptomatology. In conclusion, FCS measured by Quantra® system and its combination with D-dimer could be established as a powerful tool to identify poor prognosis in COVID-19 patients on hospital admission | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a communicable diseases | |
650 | 4 | |a diagnosis | |
650 | 4 | |a hematology | |
650 | 4 | |a thrombosis | |
650 | 7 | |a Biomarkers |2 NLM | |
650 | 7 | |a Fibrin Fibrinogen Degradation Products |2 NLM | |
650 | 7 | |a Fibrinogen |2 NLM | |
650 | 7 | |a 9001-32-5 |2 NLM | |
700 | 1 | |a Fernández-Bello, Ihosvany |e verfasserin |4 aut | |
700 | 1 | |a Martín-Téllez, Sandra |e verfasserin |4 aut | |
700 | 1 | |a Doblas-Márquez, Alberto |e verfasserin |4 aut | |
700 | 1 | |a Tesfay, Yohannes |e verfasserin |4 aut | |
700 | 1 | |a Márquez-Gómez, Ignacio |e verfasserin |4 aut | |
700 | 1 | |a Reguera-Iglesias, José María |e verfasserin |4 aut | |
700 | 1 | |a Muñoz-Pérez, Manuel Isidro |e verfasserin |4 aut | |
700 | 1 | |a Montaño, Adrián |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis |d 1998 |g 28(2022) vom: 01. Jan., Seite 10760296221112085 |w (DE-627)NLM094498261 |x 1938-2723 |7 nnns |
773 | 1 | 8 | |g volume:28 |g year:2022 |g day:01 |g month:01 |g pages:10760296221112085 |
856 | 4 | 0 | |u http://dx.doi.org/10.1177/10760296221112085 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 28 |j 2022 |b 01 |c 01 |h 10760296221112085 |